MET and lung carcinoma: Targets of miR-22-3p involved in lung cancer progression included yes-associated protein (YAP1) (He et al. 2020), MET (Yang et al. 2021), ATP citrate lyase (ACLY) (Xin et al. 2016), enolase1 (ENO1) (Zhou et al. 2019), and MALAT1 (Li et al. 2020).